Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ELVN, IMRA | Enliven Therapeutics, Inc. | Chief Scientific Officer | $18.8M | -$1.79M | -8.68% | Sep 26, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|